Virugenic action of silkworm desoxyribonucleate.

K. Yamafuji,F. Yoshihara,J. Mukai,M. Sato

1957-01-30

Abstract:

What problem does this paper attempt to address?

Tumour Microenvironment-Responsive Semiconducting Polymer-Based Self-Assembling Nanotheranostics

Zhen Yang,Yunlu Dai,Lingling Shan,Zheyu Shen,Zhantong Wang,Bryant C. Yung,Orit Jacobson,Yijing Liu,Wei Tang,Sheng Wang,Lisen Lin,Gang Niu,Pintong Huang,Xiaoyuan Chen

DOI: https://doi.org/10.1039/c8nh00307f

2019-01-01

Nanoscale Horizons

Abstract:A Pt prodrug polyphenol and gadolinium ion loaded cancer theranostics nanoplatform based on a mild acidic pH and thermal sensitive polymer was designed for photoacoustic (PA)/magnetic resonance (MR)/positron emission tomography (PET) multimodal imaging-guided chemo-photothermal combination therapy. The Pt drug release can be controlled by tumour-specific acidic pH and heat generated by external NIR irradiation. The nanoparticles were stable under normal physiological environments and released the drug under the acidic pH of tumours and NIR laser irradiation, which can reduce the side effects of the drug to normal organs. Moreover, the MR signal can be significantly enhanced (approximate to 3-fold increase in T-1 relaxivity) under the acidic tumour microenvironment, which is favorable for cancer diagnosis. The nanoparticles exhibited excellent tumour accumulation and led to complete tumour eradication with low power NIR laser irradiation. This promising approach provides a new avenue for imaging-guided combination therapy.
Theranostic Nanoplatform Based on Polydopamine-Coated Magnetic Mesoporous Silicon for Precise Cancer Triplex Nanotherapy and Multimodal Imaging

Yuanyuan Gao,Yujia Luo,Wenyu Chen,Xinrui Xue,Chujie Xiao,Kun Wei

DOI: https://doi.org/10.1021/acs.analchem.4c02244

2024-08-20

Abstract:Although targeted therapy has revolutionized oncotherapy, engineering a versatile oncotherapy nanoplatform integrating both diagnostics and therapeutics has always been an intractable challenge to overcome the limitations of monotherapy. Herein, a theranostics platform based on DI/MP-MB has successfully realized the fluorescence detection of disease marker miR-21 and the gene/photothermal/chemo triple synergetic cancer therapy, which can trace the tumor through photothermal and fluorescence dual-mode imaging and overcome the limitations of monotherapy to improve the treatment efficiency of tumors. DI/MP-MB was prepared by magnetic mesoporous silicon nanoparticles (M-MSNs) loaded with doxorubicin (Dox) and new indocyanine green (IR820), and subsequently coating polydopamine as a "gatekeeper", followed by the surface adsorbed with molecular beacons capable of targeting miR-21 for responsive imaging. Under the action of enhanced permeability retention and external magnetic field, DI/MP-MB were targeted and selectively accumulated in the tumor. MiR-21 MB hybridized with miR-21 to form a double strand, which led to the desorption of miR-21 MB from the polydopamine surface and the fluorescence recovery to realize gene silencing and fluorescence imaging for tracking the treatment process. Meanwhile, with the response to the near-infrared irradiation and the tumor's microacid environment, the outer layer polydopamine will decompose, releasing Dox and IR820 to realize chemotherapy and photothermal therapy. Finally, the ability of DI/MP-MB to efficiently suppress tumor growth was comprehensively assessed and validated both in vitro and in vivo. Noteworthily, the excellent anticancer efficiency by the synergistic effect of gene/photothermal/chemo triple therapy of DI/MP-MB makes it an ideal nanoplatform for tumor therapy and imaging.
Multiplexed Imaging with Coordination Nanoparticles for Cancer Diagnosis and Therapy

Jie Feng,Zhen Xu,Dan Luo,Xiaoqing Liu

DOI: https://doi.org/10.1021/acsabm.9b01038

2020-01-01

ACS Applied Bio Materials

Abstract:Multiplexed imaging offers great potential for precise and accurate diagnosis and therapy. Integrating multiplexed imaging with theranostics is promising to develop cancer therapeutics and diagnostics. However, the lack of versatile platforms with inherent different modalities and various probes hinders the potential of multiplexing imaging for cancer diagnosis and therapy. Here, we demonstrate that multiplexed imaging with advanced theranostic nanomaterials provides a potent method for cancer diagnostics and therapeutics both in vitro and in vivo. Unlike previous theranostic nanoplatforms, the prepared coordination nanomaterials have designable functionalities that are capable of imaging multiple intracellular biomarkers, multiple modality imaging, and photothermal ablation of tumor. Strikingly, this nanoplatform could specifically detect and image different tumor-related mRNAs simultaneously; allow infrared thermal, photoacoustic, and magnetic resonance imaging; and enable effective photothermal therapy to inhibit tumor growth in the MCF-7-derived mice xenograft tumor model. This study suggests that the nanoplatforms with designable functionalities may ultimately enable monitoring cancer processes, therapeutic mechanisms, and treatment outcomes. Exploring and exploiting multiplexed imaging with versatile theranostic nanoparticles may offer a powerful framework for precision medicine.
Ternary-Responsive Drug Delivery with Activatable Dual Mode Contrast-Enhanced in Vivo Imaging

Shuangshuang Ren,Jie Yang,Lan Ma,Xincong Li,Wenlei Wu,Chao Liu,Jian He,Leiying Miao

DOI: https://doi.org/10.1021/acsami.8b10564

IF: 9.5

2018-01-01

ACS Applied Materials & Interfaces

Abstract:Designing a smart nanotheranostic system has recently attracted tremendous attention and is highly desirable for realizing targeted cancer therapy and early diagnosis. Herein we report the fabrication of smart nanotheranostic system using multiresponsive gatekeeping protocol of mesoporous silica nanoparticles (MSN). Acid, oxidative stress and redox sensitive manganese oxide (MnO x) coated superparamagnetic iron oxide nanoparticle (SPION) were employed as nanolids to regulate the camptothecin drug release from the channels of mesoporous silica and achieve responsive dual-mode MRI contrast. The nonvehicle showed high magnetization and T2 contrast in magnetic resonance imaging (MRI) due to the significant density of SPION onto the surface of MSN, and at the same time the MnO x shell degradation release Mn2+ which enhanced the T1MRI visualization. The efficacy of responsive drug delivery system was investigated on pancreatic cancer cells and tumor-bearing mice, and results reinforced that MnO x-SPION@MSN@CPT nonvehicle is efficacious against cancer cells. We envision that our unique and multiresponsive nanoplatform may find applications in effective delivering of imaging and therapeutic agents to wide range of diseases besides cancer.
MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal therapy and chemodynamic therapy

Yupeng Shi,Mengyang Zhou,Yong Zhang,Yifei Wang,Jingliang Cheng

DOI: https://doi.org/10.1016/j.actbio.2022.12.053

IF: 10.633

2022-12-30

Acta Biomaterialia

Abstract:Image-guided stimulus-responsive theranostics are beneficial for identifying malignant lesions and integrating multiple cell-killing mechanisms to enhance tumor cell clearance. Herein, an intelligent dual-responsive nanostructure (HSPMH-DOX) was developed for magnetic resonance imaging (MRI)-guided synergistic chemo-photothermal therapy (PTT) and chemodynamic therapy (CDT). The core-shell nanostructure was synthesized by layering polydopamine (PDA), manganese oxide (MnO 2 ), and hyaluronic acid (HA) onto drug-loaded hollow mesoporous silica nanoparticles (HS). The constructed nanoagent has both endogenous and external dual responses. The tumor microenvironment (pH/GSH) can trigger the degradation of gatekeeper (MnO 2 and PDA), resulting in the release of anti-tumor drugs, whereas external near-infrared light irradiation can accelerate the degradation process and generate local overheating, resulting in PTT. Notably, MnO 2 can not only consume intracellular GSH to enhance CDT but also release Mn 2+ for precise localization of tumor tissues using MRI. Both in vitro and in vivo experiments showed that the prepared dual-response nanoagent satisfied biocompatibility, targeting, and the great efficiency of MRI-guided combined therapy. In animal models, combining chemo-PTT and CDT can eradicate tumors in less than two weeks. This work could pave the way for a wide range of stimulus-responsive synergistic theranostic applications, including MRI, chemo-photothermal therapy, and chemodynmic therapy. Statement of Significance Low bioavailability and severe side effects remain the major limitations of conventional cancer chemotherapy. Image-guided combination therapy can alleviate these problems and improve tumor-specific therapy. In the present study, the anticancer drug doxorubicin was encapsulated in a core-shell hollow mesoporous silica nanostructure (HSPMH-DOX), enabling MRI-guided targeted release under both endogenous and external dual stimuli. Moreover, the photothermal and nanoenzymatic effects of nanomedicine can cause local overheating in the tumor and amplify the intracellular CDT effect, accelerating tumor eradication. Systematic evaluations in vitro and in vivo confirmed that nanomedicine enables highly effective MRI-guided synergistic chemo-photothermal and chemodynamic therapy. This work offers a promising therapeutic strategy for precise anti-tumor applications.

engineering, biomedical,materials science, biomaterials
Dual-responsive nanoplatform for integrated cancer diagnosis and therapy: Unleashing the power of tumor microenvironment

Rui Ma,Peng Zhang,Xiuying Chen,Mengdi Zhang,Qinghe Han,Qinghai Yuan

DOI: https://doi.org/10.3389/fchem.2024.1475131

IF: 5.5

2024-10-09

Frontiers in Chemistry

Abstract:Chemodynamic therapy (CDT), designed to trigger a tumor-specific hydrogen peroxide (H 2 O 2 ) reaction generating highly toxic hydroxyl radicals (·OH), has been investigated for cancer treatment. Unfortunately, the limited Fenton or Fenton-like reaction rate and the significant impact of excessive reducing glutathione (GSH) in the tumor microenvironment (TME) have severely compromised the effectiveness of CDT. To address this issue, we designed a dual-responsive nanoplatform utilizing a metal-polyphenol network (MPN) -coated multi-caged IrO x for efficient anti-tumor therapy in response to the acidic TME and intracellular excess of GSH, in which MPN composed of Fe 3+ and tannic acid (TA). Initially, the acidic TME and intracellular excess of GSH lead to the degradation of the MPN shell, resulting in the release of Fe 3+ and exposure of the IrO x core, facilitating the efficient dual-pathway CDT. Subsequently, the nanoplatform can mitigate the attenuation of CDT by consuming the excessive GSH within the tumor. Finally, the multi-caged structure of IrO x is advantageous for effectively implementing photothermal therapy (PTT) in coordination with CDT, further enhancing the therapeutic efficacy of tumors. Moreover, the outstanding Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) (T 1 /T 2 ) multimodal imaging capabilities of IrO x @MPN enable early diagnosis and timely treatment. This work provides a typical example of the construction of a novel multifunctional platform for dual-responsive treatment of tumors.

chemistry, multidisciplinary
Nanoplatforms with synergistic redox cycles and rich defects for activatable image-guided tumor-specific therapy

Hui Zhu,Xinjie Yin,Yue Zhou,Suying Xu,Tony D. James,Leyu Wang

DOI: https://doi.org/10.1016/j.chempr.2022.06.006

IF: 23.5

2022-09-08

Chem

Abstract:Multifunctional nanoplatforms for the early diagnosis and treatment of deep-seated tumors with high specificity are particularly desirable but face many challenges. Herein, nanoplatforms containing copper/manganese chalcogenide nanoflowers (CMC NFs) and 19F probes have been developed, which exhibit enhanced therapeutic efficiency and activatable 19F magnetic resonance imaging (MRI) capability within a tumor microenvironment (TME). CMC NFs containing synergistic redox pairs (Cuox/Cured, Mnox/Mnred) and rich defects acted as integrated cascade enzyme mimics to effectively destroy the redox homeostasis of tumors via generation of reactive oxygen species (ROS) and GSH depletion. In addition, the 19F MRI signal could be switched on by attenuation of the paramagnetic relaxation enhancement (PRE) effect under TME conditions, affording a TME-activatable 19F MRI-guided tumor-specific chemodynamic therapeutic. These nanoplatforms could simultaneously boost therapeutic efficacy and regulate signal output, exhibiting significant potential for in vivo drug tracking and deep-seated tumor diagnosis and treatment.

chemistry, multidisciplinary
A Tumor Microenvironment-Responsive Core-Shell Tecto Dendrimer Nanoplatform for Magnetic Resonance Imaging-Guided and Cuproptosis-Promoted Chemo-Chemodynamic Therapy.

Cheng Ni,Zhijun Ouyang,Gaoming Li,Junjie Liu,Xueyan Cao,Linfeng Zheng,Xiangyang Shi,Rui Guo

DOI: https://doi.org/10.1016/j.actbio.2023.04.003

IF: 10.633

2023-01-01

Acta Biomaterialia

Abstract:Theranostic nanoplatforms for combination tumor therapy have gained lots of attention recently due to the optimized therapeutic efficiency and simultaneous diagnosis performance. Herein, a novel tumor microenvironment (TME)-responsive core-shell tecto dendrimer (CSTD) was assembled by phenylboronic acid- and mannose-modified poly(amidoamine) dendrimers via the phenylboronic ester bonds that are responsive to low pH and reactive oxygen species (ROS), and efficiently loaded with copper ions and chemotherapeutic drug disulfiram (DSF) for tumor-targeted magnetic resonance (MR) imaging and cuproptosis-promoted chemo-chemodynamic therapy. The formed CSTD-Cu(II)@DSF could be specifically taken up by MCF-7 breast cancer cells, accumulated to the tumor model after circulation, and released drugs in response to the weakly acidic TME with overexpressed ROS. The enriched intracellular Cu(II) ions could induce the oligomerization of lipoylated proteins and proteotoxic stress for cuproptosis, and lipid peroxidation for chemodynamic therapy as well. Moreover, the CSTD-Cu(II)@DSF could cause the dysfunction of mitochondria and arrest the cell cycle at the G2/M phase, leading to enhanced DSF-mediated cell apoptosis. As a result, CSTD-Cu(II)@DSF could effectively inhibit the growth of MCF-7 tumors by a combination therapy strategy integrating chemotherapy with cuproptosis and chemodynamic therapy. Lastly, the CSTD-Cu(II)@DSF also displays Cu(II)-associated r1 relaxivity, allowing for T1-weighted real-time MR imaging of tumors in vivo. The developed tumor-targeted and TME-responsive CSTD-based nanomedicine formulation may be developed for accurate diagnosis and synergistic treatment of other cancer types. STATEMENT OF SIGNIFICANCE: Constructing an effective nanoplatform for the combination of therapeutic effects and real-time tumor imaging remains a challenge. In this study, we reported for the first time an all-in-one tumor-targeted and tumor microenvironment (TME) responsive nanoplatform based on core-shell tecto dendrimer (CSTD) for the cuproptosis-promoted chemo-chemodynamic therapy and enhanced MR imaging. The efficient loading, selective tumor-targeting, and TME-responsive release of Cu(II) and disulfiram could enhance the intracellular accumulation of drugs, induce cuproptosis of cancer cells, and amplify the synergistic chemo-chemodynamic therapeutic effect, resulting in enhanced MR imaging and accelerated tumor eradication. This study sheds new light on the development of theranostic nanoplatforms for early accurate diagnosis and effective treatment of cancers.
Tumor microenvironment-responsive multifunctional nanoplatform with selective toxicity for MRI-guided photothermal/photodynamic/nitric oxide combined cancer therapy

Shihao Zhou,Chengguang Wu,Pengfei Shen,Liming Zhou,Wenbo Wang,Kai Lv,Chengxiu Wei,Guowei Li,Dong Ma,Wei Xue

DOI: https://doi.org/10.1016/j.cej.2024.148618

IF: 15.1

2024-01-19

Chemical Engineering Journal

Abstract:The trade-off in nanomaterials-based cancer therapy between safety and therapeutic efficacy remains a significant challenge to overcome in the long run. In this context, we have designed a tumor microenvironment (pH, H 2 O 2 )-responsive multifunctional nanoplatform with a core–shell structure (C/B@M) for magnetic resonance imaging (MRI)-guided photothermal (PTT) /photodynamic (PDT) /nitric oxide (NO) combined cancer therapy. The pH/H 2 O 2 -responsive MnO 2 coating not only shields from light, preventing the premature release of singlet oxygen, which is non-specifically toxic, but also generates O 2 to alleviate tumor hypoxia, enhancing PDT efficacy. The degradation of MnO 2 to Mn 2+ aids in precise tumor localization for MRI-guided irradiation, thereby reducing the risk of inadvertent damage to normal cells. Once the shell is degraded within the tumor, the covalent organic framework (COF) core, crafted from porphyrin, produces singlet oxygen and thermal effects upon exposure to infrared light irradiation (660 nm). Concurrently, BNN6 decomposes under photothermal stimulation, releasing NO for gas therapy, which further ameliorates the tumor's hypoxic microenvironment, enabling MRI imaging-guided multimodal combined tumor treatments. The introduced C/B@M, with its selective toxicity, offers a novel approach to designing multifunctional nanoplatforms, addressing the intrinsic balance between safety and tumor-killing efficacy.

engineering, chemical, environmental
Multi-responsive nanotheranostics with enhanced tumor penetration and oxygen self-producing capacities for multimodal synergistic cancer therapy

Shuangquan Gou,Nanxi Chen,Xiaoai Wu,Menghang Zu,Shixiong Yi,Binwu Ying,Fangyin Dai,Bowen Ke,Bo Xiao

DOI: https://doi.org/10.1016/j.apsb.2021.07.001

IF: 14.903

2022-01-01

Acta Pharmaceutica Sinica B

Abstract:Incorporation of multiple functions into one nanoplatform can improve cancer diagnostic efficacy and enhance anti-cancer outcomes. Here, we constructed doxorubicin (DOX)-loaded silk fibroin-based nanoparticles (NPs) with surface functionalization by photosensitizer (N770). The obtained nanotheranostics () had desirable particle size (157 nm) and negative surface charge (−25 mV). These NPs presented excellent oxygen-generating capacity and responded to a quadruple of stimuli (acidic solution, reactive oxygen species, glutathione, and hyperthermia). Surface functionalization of with N770 could endow them with active internalization by cancerous cell lines, but not by normal cells. Furthermore, the intracellular NPs were found to be preferentially retained in mitochondria, which were also efficient for near-infrared (NIR) fluorescence imaging, photothermal imaging, and photoacoustic imaging. Meanwhile, DOX could spontaneously accumulate in the nucleus. Importantly, a mouse test group treated with plus NIR irradiation achieved the best tumor retardation effect among all treatment groups based on tumor-bearing mouse models and a patient-derived xenograft model, demonstrating the unprecedented therapeutic effects of trimodal imaging-guided mitochondrial phototherapy (photothermal therapy and photodynamic therapy) and chemotherapy. Therefore, the present study brings new insight into the exploitation of an easy-to-use, versatile, and robust nanoplatform for programmable targeting, imaging, and applying synergistic therapy to tumors.

pharmacology & pharmacy
A Redox-Activated Theranostic Nanoagent: Toward Multi-Mode Imaging Guided Chemo-Photothermal Therapy

Ting-Ting Zhang,Cong-Hui Xu,Wei Zhao,Yu Gu,Xiang-Ling Li,Jing-Juan Xu,Hong-Yuan Chen

DOI: https://doi.org/10.1039/c8sc02446d

IF: 8.4

2018-01-01

Chemical Science

Abstract:Development of tumor microenvironment responsive and modulating theranostic nano-systems is of great importance for specific and efficient cancer therapy. Herein, we report a redox-sensitive nanoagent combining manganese dioxide (MnO2) and gold nanoshell coated silicon nanoparticles for synergistic chemo-photothermal therapy of hypoxia solid tumors. In highly reducing tumor tissues, the outer MnO2 nanosheet with the loaded drug would be dissociated by intracellular glutathione (GSH), resulting in on-demand drug release, as well as generating Mn2+ ions which provided high contrast magnetic resonance imaging (MRI), and fluorescence imaging (FI) in vitro and in vivo. While upon near-infrared (NIR) light irradiation, the gold nanoshell modulated the hypoxic tumor microenvironment via increasing blood flow, achieving enhanced photothermal therapy (PTT) and chemotherapy. After tail vein injection into tumor-bearing mice and monitoring in real time, the intelligent redox-activated nanoagent exhibited high tumor accumulation and powerful synergistic chemo-photothermal therapy efficiency. The proposed work developed a noninvasive strategy to modulate the tumor microenvironment and enhance the anticancer therapeutic effect. We believe that this single nano-platform exhibits promising potential as a comprehensive theranostic agent to enhance the efficacies of synergistic cancer therapy.
A theranostic nanocomposite system based on radial mesoporous silica hybridized with Fe3O4 nanoparticles for targeted magnetic field responsive chemotherapy of breast cancer

Qin Gao,Wensheng Xie,Yu Wang,Dan Wang,Zhenhu Guo,Fei Gao,Lingyun Zhao,Qiang Cai

DOI: https://doi.org/10.1039/c7ra12446e

IF: 4.036

2018-01-01

RSC Advances

Abstract:Achieving accumulation of a target drug in tumor tissue, optimal release behavior and concurrent diagnostic imaging with therapy (theranostic) requires an ideal chemotherapy protocol that involves the responsive control of drug delivery. In the current study, we report the construction of a novel theranostic drug delivery system based on radial mesoporous silica, which is hybridized with multiscale magnetic nanoparticles for MRI-guided and alternative magnetic field (AMF) responsive chemotherapy for breast cancer. Superparamagnetic iron oxide nanoparticles (IONPs) with multiscale sizes were prepared via a hydrothermal method (for larger IONPs, lIO NPs) and a thermal decomposition method (for ultra-small IONPs, uIO NPs). lIO NPs act as the heat mediator that is responsive to the AMF, while uIO NPs act as the T-2 contrast agent for MRI. Mesoporous silica nanoparticles with radially oriented mesochannels were further in situ grown onto the surfaces of the lIO NPs, and both the uIO NPs and doxorubicin, an anti-cancer drug, can be readily incorporated within the mesochannels. To endow the as-prepared doxorubicin-loaded nano-hybrids with a good targeting ability, the surfaces of the particles were modified with folic acid (FA). This prepared drug delivery system based on magnetic/silica nanocomposites showed high drug loading efficiency and AMF stimuli responsive release properties. Meanwhile, in vitro MRI measurements revealed an excellent MRI contrast effect with a high relaxation value of 308 mM(-1) s(-1). Furthermore, both in vitro cytotoxicity analysis and in vivo anti-tumor effect evaluation demonstrated that the drug delivery system possesses great potential as an MRI-guided stimuli-responsive theranostic platform for effective active targeting chemotherapy of cancer.
Recent development of pH‐responsive theranostic nanoplatforms for magnetic resonance imaging‐guided cancer therapy

Xu Li,Renye Yue,Guoqiang Guan,Cheng Zhang,Ying Zhou,Guosheng Song

DOI: https://doi.org/10.1002/EXP.20220002

2023-04-01

Exploration

Abstract:pH‐responsive theranostic nanoplatforms have provided a great opportunity in the combat with cancer. Herein, we summarize the recent progress in pH‐responsive theranostic nanoplatforms that integrate magnetic resonance imaging‐based diagnostics and a variety of therapeutic modes for tumor detection, imaging, and therapy. The acidic characteristic of the tumor site is one of the most well‐known features and provides a series of opportunities for cancer‐specific theranostic strategies. In this regard, pH‐responsive theranostic nanoplatforms that integrate diagnostic and therapeutic capabilities are highly developed. The fluidity of the tumor microenvironment (TME), with its temporal and spatial heterogeneities, makes noninvasive molecular magnetic resonance imaging (MRI) technology very desirable for imaging TME constituents and developing MRI‐guided theranostic nanoplatforms for tumor‐specific treatments. Therefore, various MRI‐based theranostic strategies which employ assorted therapeutic modes have been drawn up for more efficient cancer therapy through the raised local concentration of therapeutic agents in pathological tissues. In this review, we summarize the pH‐responsive mechanisms of organic components (including polymers, biological molecules, and organosilicas) as well as inorganic components (including metal coordination compounds, metal oxides, and metal salts) of theranostic nanoplatforms. Furthermore, we review the designs and applications of pH‐responsive theranostic nanoplatforms for the diagnosis and treatment of cancer. In addition, the challenges and prospects in developing theranostic nanoplatforms with pH‐responsiveness for cancer diagnosis and therapy are discussed.
Tumor-targeted Gd-doped mesoporous Fe 3 O 4 nanoparticles for T 1 /T 2 MR imaging guided synergistic cancer therapy

Shaohui Zheng,Shang Jin,Min Jiao,Wenjun Wang,Xiaoyu Zhou,Jie Xu,Yong Wang,Peipei Dou,Zhen Jin,Changyu Wu,Jingjing Li,Xinting Ge,Kai Xu

DOI: https://doi.org/10.1080/10717544.2021.1909177

IF: 6.819

2021-01-01

Drug Delivery

Abstract:In this study, a novel intelligent nanoplatform to integrate multiple imaging and therapeutic functions for targeted cancer theranostics. The nanoplatform, DOX@Gd-MFe3O4 NPs, was constructed Gd-doped mesoporous Fe3O4 nanoparticles following with the doxorubicin (DOX) loading in the mesopores of the NPs. The DOX@Gd-MFe3O4 NPs exhibited good properties in colloidal dispersity, photothermal conversion, NIR triggered drug release, and high T1/T2 relaxicity rate (r1=9.64 mM−1s−1, r2= 177.71 mM−1s−1). Benefiting from the high MR contrast, DOX@Gd-MFe3O4 NPs enabled simultaneous T1/T2 dual-modal MR imagining on 4T1 bearing mice in vivo and the MR contrast effect was further strengthened by external magnetic field. In addition, the DOX@Gd-MFe3O4 NPs revealed the strongest inhibition to the growth of 4T1 in vitro and in vivo under NIR irradiation and guidance of external magnetic field. Moreover, biosafety was also validated by in vitro and in vivo tests. Thus, the prepared DOX@Gd-MFe3O4 NPs would provide a promising intelligent nanoplatform for dual-modal MR imagining guided synergistic therapy in cancer theranostics.

pharmacology & pharmacy
An integrated nanoplatform for theranostics via multifunctional core–shell ferrite nanocubes

Li Wang,Yuping Yan,Min Wang,Hong Yang,Zhiguo Zhou,Chen Peng,Shiping Yang

DOI: https://doi.org/10.1039/c5tb01910a

IF: 7.571

2016-01-01

Journal of Materials Chemistry B

Abstract:Magnetic core-shell ferrite nanocubes (MNCs) were prepared by a two-step pyrolysis. The MNCs not only exhibit an excellent magnetothermal effect, but also can be used as T-2 magnetic resonance (MR) imaging agents. To obtain their good biocompatibility and targeting ability, MNCs were modified with poly(ethylene glycol) (PEG) and hyaluronic acid (HA). To further construct an integrated nanoplatform for theranostics, doxorubicin (DOX) was loaded onto the surface of MNCs by pH and heat sensitive chemical bonding. Notably, the MNCs showed a great stability and magnetothermal effect. Moreover, they showed negligible toxicity and synergistic therapy in vitro. Meanwhile, their MR imaging in vivo was further verified. A novel integrated nanoplatform facilitates excellent targeted MR imaging guided synergism of magnetothermal and chemotherapy. The multifunctional nanocubes will be capable of playing a vital role in future cancer therapy.
Synthesis and Application of Multifunctional Magnetic Mesoporous Nanomaterials with Redox Reaction and NIR Response in Tumor Treatment

Jiaxuan Guo,Yunxia Hu,Taiyu Zhou,Xiayu Liang,Lei Tian,Pei Xie,Chengzheng Jia

DOI: https://doi.org/10.1016/j.colsurfa.2024.134110

IF: 5.518

2024-05-03

Colloids and Surfaces A Physicochemical and Engineering Aspects

Abstract:In recent years, the novel minimally invasive combination therapy for tumors has garnered widespread attention due to its controllable therapeutic target, effective combination therapy outcome, and minimal toxic side effects. This study integrated inorganic nanospheres of ferric oxide (Fe 3 O 4 ) with mesoporous silica nanoparticles (MSN), along with polymeric organic polymers—polyaniline (PANI) and hyaluronic acid (HA)—to create a multifunctional tumor treatment platform (Fe 3 O 4 @MSN@PANI@HA), aiming to enhance the efficacy of therapies that have monotherapy limitations. The Fe 2+ within the Fe 3 O 4 @MSN@PANI@HA nanoparticles can react with the unique hydrogen peroxide present in the tumor microenvironment to generate hydroxyl radicals (·OH), which possess cytotoxic properties that can selectively eradicate tumor cells, thereby facilitating chemodynamic therapy (CDT). Moreover, Fe 3 O 4 @MSN@PANI@HA nanoparticles, when loaded with the chemotherapy drug doxorubicin hydrochloride (DOX), yield Fe 3 O 4 @MSN@PANI@HA-DOX nanoparticles. It has been demonstrated that these nanoparticles exhibit commendable drug-loading efficiency and controlled drug-release capabilities, contributing to the chemotherapy of tumors. The inclusion of PANI in the Fe 3 O 4 @MSN@PANI@HA nanoparticles endows them with an exceptional photothermal conversion capability. Upon exposure to an 808-nm near-infrared laser (NIR), the photothermal conversion efficiency of the composite nanomaterials reaches 42.76%, thereby enabling photothermal therapy (PTT) through the thermal ablation of tumor cells. The HA component of the composite nanoparticles provides excellent biocompatibility and a sustained drug-release effect. Simultaneously, it could target tumor cells by recognizing specific receptors that are overexpressed on the cell surfaces, directing the transport of the composite nanoparticles to the tumor site, and selectively destroying tumor cells. This paper confirms the potent therapeutic impact of composite nanoparticles on tumors and offers a novel perspective for designing multifunctional composite nanomaterials.

chemistry, physical
Developing Smart Nanoparticles Responsive to the Tumor Micro-Environment for Enhanced Synergism of Thermo-Chemotherapy With PA/MR Bimodal Imaging

Mingfang Luo,Yijie Lv,Xunrong Luo,Qingfa Ren,Zhenbo Sun,Tianping Li,Ailing Wang,Yan Liu,Caixia Yang,Xianglin Li

DOI: https://doi.org/10.3389/fbioe.2022.799610

IF: 5.7

2022-02-21

Frontiers in Bioengineering and Biotechnology

Abstract:With the development of nanotechnology, a theranostics nanoplatform can have broad applications in multimodal image-guided combination treatment in cancer precision medicine. To overcome the limitations of a single diagnostic imaging mode and a single chemotherapeutic approach, we intend to combat tumor growth and provide therapeutic interventions by integrating multimodal imaging capabilities and effective combination therapies on an advanced platform. So, we have constructed IO@MnO 2 @DOX (IMD) hybrid nanoparticles composed of superparamagnetic iron oxide (IO), manganese dioxide (MnO 2 ), and doxorubicin (DOX). The nano-platform could achieve efficient T2-T1 magnetic resonance (MR) imaging, switchable photoacoustic (PA) imaging, and tumor microenvironment (TME)-responsive DOX release and achieve enhanced synergism of magnetic hyperthermia and chemotherapy with PA/MR bimodal imaging. The results show that IMD has excellent heating properties when exposed to an alternating magnetic field (AMF). Therefore, it can be used as an inducer for tumor synergism therapy with chemotherapy and hyperthermia. In the TME, the IMD nanoparticle was degraded, accompanied by DOX release. Moreover, in vivo experimental results show that the smart nanoparticles had excellent T2-T1 MR and PA imaging capabilities and an excellent synergistic effect of magnetic hyperthermia and chemotherapy. IMD nanoparticles could significantly inhibit tumor growth in tumor-bearing mice with negligible side effects. In conclusion, smart IMD nanoparticles have the potential for tumor diagnosis and growth inhibition as integrated diagnostic nanoprobes.

multidisciplinary sciences
MnO2-Functionalized Co-P Nanocomposite: A New Theranostic Agent for Ph-Triggered T1/T2 Dual-Modality Magnetic Resonance Imaging-Guided Chemo-photothermal Synergistic Therapy.

Longhai Jin,Jianhua Liu,Ying Tang,Lanqing Cao,Tianqi Zhang,Qinghai Yuan,Yinghui Wang,Hongjie Zhang

DOI: https://doi.org/10.1021/acsami.7b10608

IF: 9.5

2017-01-01

ACS Applied Materials & Interfaces

Abstract:Construction of stimuli-responsive theranostic nanoagents that can increase the accuracy of imaging diagnosis and boost the therapeutic efficacy has been demonstrated for a promising approach for diagnosis and treatment of cancer. Herein, we constructed a novel theranostic agent with Co-P nanocomposites as core, mesoporous silica as shell, and manganese dioxide (MnO2) nanosheets as gatekeeper, which have been employed for pH-activatable T1/T2 dual-modality magnetic resonance imaging (MRI)-guided chemotherapeutical and photothermal combination anticancer therapy in vitro and in vivo. Co-P core-enabled theranostic platform could be applied for both photothermal therapy and T2-weighted MRI in the normal circulation owing to its strong near-infrared absorbance and intrinsic magnetic properties. In the acidic environment of tumors, MnO2 cap could be dissolved into Mn2+ ions to not only realize pH-responsive on-demand drug release but also activate T1-weighted MRI contrast enhancement. Such T1/T2 dual-mode MR imaging provides further comprehensive details and accurate information for tumor diagnosis, and the on-demand chemo-photothermal synergetic therapy greatly improved the therapeutic effectiveness and effectively mitigated side effects. These findings demonstrate that Co-P@mSiO2@DOX-MnO2 are promising as pH-responsive theranostic agents for tumor diagnosis and treatment, and stimulate interest in exploration of novel stimuli-responsive theranostic nanoagents which posssess good potential for clinical application in the future.
A versatile nanoplatform for synergistic chemo-photothermal therapy and multimodal imaging against breast cancer

Tingting Li,Yue Geng,Hanxi Zhang,Jing Wang,Yi Feng,Zhongyuan Chen,Xiaoxue Xie,Xiang Qin,Shun Li,Chunhui Wu,Yiyao Liu,Hong Yang

DOI: https://doi.org/10.1080/17425247.2020.1736033

2020-03-03

Expert Opinion on Drug Delivery

Abstract:Objectives: Mesoporous silica nanoparticles (MSNs) with unique advantages can combine multiple functionalities including imaging and therapeutic into one single platform that can provide personalized diagnosis and treatment. In this study, we fabricated a multifunctional nanocomplex for the delivery of a classic chemotherapy drug (Doxorubicin, DOX) and a near-infrared (NIR) dye (indocyanine green, ICG) based on mesoporous silica-coated Fe3O4 nanoparticles. Hyaluronic acid (HA) was conjugated onto the surface of the nanocomplex to respond to hyaluronidase (HAase). the final complex is short for M-MSN/HA/DI.Methods: The successful synthesis of M-MSN-HA/DI nanocomplex was confirmed by Fourier transform infrared spectroscopy and UV–vis spectrometer. The photothermal conversion efficiency and antitumor efficiency in breast cancer bearing mice were further evaluated.Results: M-MSN/HA/DI showed preeminent T2 MR and fluorescence (FL) imaging ability, and the release of DOX was accelerated in the presence of HAase. The nanocomplex generated high heat upon 808 nm NIR irradiation and efficiently induced apoptosis in breast cancer cells. The in vivo studies demonstrated that the final nanocomplex can inhibit tumor growth with minimal systemic toxicity upon 808 nm NIR irradiation.Conclusion: Collectively, our work offers a preclinical proof of concept for a multifunctional drug delivery system for cancer therapy and imaging,which could achieve efficient application for cancer.

pharmacology & pharmacy
A versatile metal–organic nanoplatform in combination with CXCR4 antagonist and PD-L1 inhibitor for multimodal synergistic cancer therapy and MRI-guided tumor imaging

Di Liu,Hongliang He,Fei Kong,Yixiang Cao,Fengchao Zang,Ming Ma,Ning Gu,Yu Zhang

DOI: https://doi.org/10.1016/j.nantod.2022.101689

IF: 17.4

2022-11-19

Nano Today

Abstract:Currently, multimodal synergistic nanoplatform emerges as an important cancer therapy paradigm, however, multimodal synergistic theranostic nanoplatform remains to be developed. Herein, using the mouse model of breast cancer, a versatile multimodal synergistic theranostic nanoplatform is rationally designed and synthesized for enhancing chemodynamic therapy (CDT), overcoming immunosuppression within tumor microenvironment, and inhibiting metastasis as well as tracking tumor. To fulfill our design, a composite Fe/Mn magnetic nanoparticle is first synthesized by loading with Fe 3 O 4 and BMS-202 (PD-L1 inhibitor) within a poly(lactide-co-glycolide)-based nanoparticle core, which are further modified with in situ synthesis of MnO 2 layer. Then, the composite metal-organic nanoparticle is coated with two targeting moieties hyaluronic acid (HA) and AMD3100 (CXCR4 antagonist), respectively, to achieve the multimodal synergistic theranostic nanoplatform (+AMD). With surface targeting modification, +AMD exhibits enhanced tumor accumulation, where it effectively consumes endogenous glutathione to generate Mn 2+ allowing for the enhanced CDT effect, alleviates tumor hypoxia by O 2 generation and reverses the tumor immunosuppression. +AMD blocks CXCR4 receptor on cancer cells, thus suppressing the CXCR4-mediated cancer metastasis and invasion. Additionally, +AMD would synchronously be achieving tumor tracking by T 1 -T 2 dual-mode magnetic resonance imaging. Collectively, this strategy holds a novel multimodal synergistic theranostics for effective cancer management.

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry

Virugenic action of silkworm desoxyribonucleate.

Tumour Microenvironment-Responsive Semiconducting Polymer-Based Self-Assembling Nanotheranostics

Theranostic Nanoplatform Based on Polydopamine-Coated Magnetic Mesoporous Silicon for Precise Cancer Triplex Nanotherapy and Multimodal Imaging

Multiplexed Imaging with Coordination Nanoparticles for Cancer Diagnosis and Therapy

Ternary-Responsive Drug Delivery with Activatable Dual Mode Contrast-Enhanced in Vivo Imaging

MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal therapy and chemodynamic therapy

Dual-responsive nanoplatform for integrated cancer diagnosis and therapy: Unleashing the power of tumor microenvironment

Nanoplatforms with synergistic redox cycles and rich defects for activatable image-guided tumor-specific therapy

A Tumor Microenvironment-Responsive Core-Shell Tecto Dendrimer Nanoplatform for Magnetic Resonance Imaging-Guided and Cuproptosis-Promoted Chemo-Chemodynamic Therapy.

Tumor microenvironment-responsive multifunctional nanoplatform with selective toxicity for MRI-guided photothermal/photodynamic/nitric oxide combined cancer therapy

Multi-responsive nanotheranostics with enhanced tumor penetration and oxygen self-producing capacities for multimodal synergistic cancer therapy

A Redox-Activated Theranostic Nanoagent: Toward Multi-Mode Imaging Guided Chemo-Photothermal Therapy

A theranostic nanocomposite system based on radial mesoporous silica hybridized with Fe3O4 nanoparticles for targeted magnetic field responsive chemotherapy of breast cancer

Recent development of pH‐responsive theranostic nanoplatforms for magnetic resonance imaging‐guided cancer therapy

Tumor-targeted Gd-doped mesoporous Fe 3 O 4 nanoparticles for T 1 /T 2 MR imaging guided synergistic cancer therapy

An integrated nanoplatform for theranostics via multifunctional core–shell ferrite nanocubes

Synthesis and Application of Multifunctional Magnetic Mesoporous Nanomaterials with Redox Reaction and NIR Response in Tumor Treatment

Developing Smart Nanoparticles Responsive to the Tumor Micro-Environment for Enhanced Synergism of Thermo-Chemotherapy With PA/MR Bimodal Imaging

MnO2-Functionalized Co-P Nanocomposite: A New Theranostic Agent for Ph-Triggered T1/T2 Dual-Modality Magnetic Resonance Imaging-Guided Chemo-photothermal Synergistic Therapy.

A versatile nanoplatform for synergistic chemo-photothermal therapy and multimodal imaging against breast cancer

A versatile metal–organic nanoplatform in combination with CXCR4 antagonist and PD-L1 inhibitor for multimodal synergistic cancer therapy and MRI-guided tumor imaging